SQUEEZE study underway

Trainee-led international research into postoperative vasopressor infusion use.

SQUEEZE is a prospective international multi-centre observational study examining postoperative vasopressor infusion use, run out of the UK and Belgium by the European Society of Anaesthesiology (ESA). 

Currently, there are more than 45 countries and 450 centres involved, with Australia contributing 10 centres from Queensland, Western Australia, New South Wales and Victoria, run by trainees with the support of regional trainee research networks. These sites include:

  • Royal Perth Hospital, WA
  • Fiona Stanley Hospital, WA
  • Sir Charles Gairdner Hospital, WA
  • Princess Alexandra Hospital, Qld
  • Logan Hospital, Qld
  • Sunshine Coast Hospital, Qld
  • QEII Jubilee Hospital, Qld
  • Wagga Wagga Base Hospital, NSW
  • Nepean Base Hospital, NSW
  • Peter MacCallum Cancer Centre, Vic


Data collection is due to start for most centres in November 2020, following a lengthy process of national ethics applications and governance approvals, and will run over the next six-12 months.

Reaching this point has been a challenge, not least because of the COVID-19 pandemic, and its success thus far can be credited to the hard work of all the trainees involved across Australia.  

Involvement in large international clinical studies such as SQUEEZE offers emerging researchers invaluable experience in the coordination of larger scale studies, as well as allowing for the collection of high quality international comparative outcome data.

If you have any questions relating to SQUEEZE, or the processes involved in setting up similar studies in Australia, please email Dr Simon Bradbeer.


Last updated 16:10 26.11.2020